Delivery Order SPE2D021DA002-SPE2D325F173X
Award Date 6/27/25
Potential Completion Date 7/2/25
Potential Value $1.6K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency, operating under the Medical Supply Chain program, awarded a delivery order to DMS Pharmaceutical Group Inc. for Twinrix vaccine syringes valued at $2,454.93. The award, issued on September 9, 2025, with an ultimate completion date of September 12, 2025, carries firm fixed-price terms under a delivery order contract type with no set-aside designation. Performance will take place at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a...
- The U.S. Department of Defense's Medical Supply Chain has awarded a delivery order valued at $1,636.62 to DMS Pharmaceutical Group Inc. for the supply of Twinrix vaccine in syringe format. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and will be performed at the...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc. for $1,636.62 on April 23, 2025, with a completion date of April 24, 2025. The award covers the supply of Twinrix vaccine syringes under a firm fixed-price delivery order structure. This award was issued without a set-aside designation and represents a draw-down from DMS Pharmaceutical Group's larger indefinite delivery contract vehicle with the...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for the supply of Twinrix vaccine in syringe format. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, received this contract award on August 13, 2025, with an ultimate completion date of August 18, 2025. The ceiling value for this delivery order is $1,636.62, and...
- The U.S. Defense Logistics Agency has awarded a delivery order valued at $4,909.86 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Twinrix vaccine in syringe format. This award was issued on June 24, 2025, with an ultimate completion date of June 27, 2025, under a firm fixed-price contract structure with no set-aside designation applied. The contract represents a direct purchase of pharmaceutical products...
- The U.S. Defense Logistics Agency (DLA), under its Medical Supply Chain program, awarded a delivery order to DMS Pharmaceutical Group Inc. on August 8, 2025, for the supply of Twinrix vaccine syringes. The contract, valued at $4,091.55 with a firm fixed-price structure, is scheduled for completion by August 13, 2025, and will be fulfilled from the contractor's location in Park Ridge, Illinois. This delivery order was awarded without a set-aside designation, allowing the vendor to compete in...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $4,091.55 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Twinrix vaccine in syringe form. This firm fixed-price delivery order, issued on June 16, 2025, with an ultimate completion date of June 20, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $8,183.10 to DMS Pharmaceutical Group Inc. on August 1, 2025, for the supply of Twinrix vaccine in syringe form. This firm fixed-price delivery order, which is expected to be completed by August 6, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger indefinite delivery contract with DLA. The contract carries no set-aside designation, allowing DMS...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the Twinrix vaccine syringe. The $2,347.29 contract has an August 23, 2023 completion date and was awarded on August 22, 2023. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles to supply pharmaceuticals and medical products in support of...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $1,636.62 to DMS Pharmaceutical Group Inc. for the supply of TWINRIX vaccine syringes. The award, made on April 30, 2025, with an ultimate completion date of May 1, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, is the prime contractor on this...